EFFECTS OF ALPHA-INTERFERON ON THEOPHYLLINE PHARMACOKINETICS AND METABOLISM

[1] BIRKETT DJ, 1985, DRUG METAB DISPOS, V13, P725

[2] CHANG KC, 1978, LANCET, V1, P1132

[3] CLARK CJ, 1979, LANCET, V1, P492

[4] CORNISH HH, 1957, J BIOL CHEM, V228, P315

[5] STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) : 529 - 537

[6] Gibaldi M., 1982, PHARMACOKINETICS

[7] GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660

[8] HENDELES L, 1983, PHARMACOTHERAPY, V3, P2

[9] THEOPHYLLINE - A REMARKABLE WINDOW TO THE HEPATIC-MICROSOMAL OXIDASES [J]. CHEST, 1982, 81 (05) : 529 - 530

[10] JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375

[1] BIRKETT DJ, 1985, DRUG METAB DISPOS, V13, P725

[2] CHANG KC, 1978, LANCET, V1, P1132

[3] CLARK CJ, 1979, LANCET, V1, P492

[4] CORNISH HH, 1957, J BIOL CHEM, V228, P315

[5] STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) : 529 - 537

[6] Gibaldi M., 1982, PHARMACOKINETICS

[7] GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660

[8] HENDELES L, 1983, PHARMACOTHERAPY, V3, P2

[9] THEOPHYLLINE - A REMARKABLE WINDOW TO THE HEPATIC-MICROSOMAL OXIDASES [J]. CHEST, 1982, 81 (05) : 529 - 530

[10] JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375